{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:50:06Z","timestamp":1778568606187,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.imlet.2024.106935","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T17:21:09Z","timestamp":1728667269000},"page":"106935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Fingolimod, an antagonist of sphingosine 1-phosphate, ameliorates Sj\u00f6gren's syndrome by reducing the number of STAT3\u2013induced germinal center B cells and increasing the number of Breg cells"],"prefix":"10.1016","volume":"270","author":[{"given":"Yeon Su","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JooYeon","family":"Jhun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Won","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Hee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Seok","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Cheon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Ram","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5715-3989","authenticated-orcid":false,"given":"Mi-La","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.imlet.2024.106935_bib0001","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41584-021-00605-2","article-title":"Epithelial-immune cell interplay in primary Sjogren syndrome salivary gland pathogenesis","volume":"17","author":"Verstappen","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.imlet.2024.106935_bib0002","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/joim.13032","article-title":"Environmental factors in the pathogenesis of primary Sjogren's syndrome","volume":"287","author":"Bjork","year":"2020","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/j.imlet.2024.106935_bib0003","first-page":"315","article-title":"Pathogenesis of primary Sjogren's syndrome beyond B lymphocytes","volume":"126","author":"Fasano","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"issue":"7","key":"10.1016\/j.imlet.2024.106935_bib0004","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1093\/rheumatology\/kez004","article-title":"T cells in primary Sjogren's syndrome: targets for early intervention","volume":"60","author":"Verstappen","year":"2021","journal-title":"Rheumatology. (Oxford)"},{"issue":"3","key":"10.1016\/j.imlet.2024.106935_bib0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3899\/jrheum.181443","article-title":"Sjogren syndrome without focal lymphocytic infiltration of the salivary glands","volume":"47","author":"Sharma","year":"2020","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.imlet.2024.106935_bib0006","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12964-023-01141-0","article-title":"Lactobacillus acidophilus and propionate attenuate Sjogren's syndrome by modulating the STIM1-STING signaling pathway","volume":"21","author":"Woo","year":"2023","journal-title":"Cell Commun. Signal."},{"issue":"6","key":"10.1016\/j.imlet.2024.106935_bib0007","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1083\/jcb.200203123","article-title":"Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis","volume":"158","author":"Stunff","year":"2002","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.imlet.2024.106935_bib0008","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.4049\/jimmunol.180.3.1921","article-title":"Role of sphingosine 1-phosphate in the pathogenesis of Sjogren's syndrome","volume":"180","author":"Sekiguchi","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2024.106935_bib0009","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00005-013-0264-8","article-title":"Sphingosine-1-phosphate: a master regulator of lymphocyte egress and immunity","volume":"62","author":"Simmons","year":"2014","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"issue":"11","key":"10.1016\/j.imlet.2024.106935_bib0010","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s40265-016-0603-2","article-title":"Sphingosine-1-Phosphate (S1P) and S1P signaling pathway: therapeutic targets in autoimmunity and inflammation","volume":"76","author":"Tsai","year":"2016","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.imlet.2024.106935_bib0011","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clim.2010.03.428","article-title":"Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model","volume":"136","author":"Tsunemi","year":"2010","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2024.106935_bib0012","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1073\/pnas.1014154108","article-title":"FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation","volume":"108","author":"Choi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2024.106935_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102549","article-title":"Fingolimod reduces salivary infiltrates and increases salivary secretion in a murine Sjogren's model","volume":"115","author":"Cohen","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imlet.2024.106935_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.684999","article-title":"The multiple roles of B cells in the pathogenesis of Sjogren's syndrome","volume":"12","author":"Du","year":"2021","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.imlet.2024.106935_bib0015","first-page":"2297","article-title":"Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjogren's syndrome","volume":"136","author":"Li","year":"2023","journal-title":"Chin. Med. J. (Engl)"},{"issue":"3","key":"10.1016\/j.imlet.2024.106935_bib0016","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2478\/rir-2022-0017","article-title":"JAK\/STAT pathway targeting in primary Sjogren syndrome","volume":"3","author":"Gandolfo","year":"2022","journal-title":"Rheumatol. Immunol. Res."},{"key":"10.1016\/j.imlet.2024.106935_bib0017","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1186\/1471-2407-14-783","article-title":"FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling","volume":"14","author":"Lu","year":"2014","journal-title":"BMC. Cancer"},{"issue":"9","key":"10.1016\/j.imlet.2024.106935_bib0018","doi-asserted-by":"crossref","first-page":"e86462","DOI":"10.1172\/jci.insight.86462","article-title":"Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation","volume":"1","author":"Tsai","year":"2016","journal-title":"JCI. Insight."},{"issue":"11","key":"10.1016\/j.imlet.2024.106935_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112467","article-title":"Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjogren's syndrome","volume":"9","author":"Kern","year":"2014","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.imlet.2024.106935_bib0020","article-title":"A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:treg balance","volume":"6","author":"Aqel","year":"2021","journal-title":"JCI. Insight."},{"issue":"1","key":"10.1016\/j.imlet.2024.106935_bib0021","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/mi.2016.35","article-title":"Sphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease","volume":"10","author":"Karuppuchamy","year":"2017","journal-title":"Mucosal. Immunol."},{"key":"10.1016\/j.imlet.2024.106935_bib0022","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sjogren syndrome","volume":"2","author":"Brito-Zeron","year":"2016","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"suppl_2","key":"10.1016\/j.imlet.2024.106935_bib0023","doi-asserted-by":"crossref","first-page":"S678","DOI":"10.1093\/ecco-jcc\/jjx107","article-title":"Targeting S1P in inflammatory bowel disease: new avenues for modulating intestinal leukocyte migration","volume":"12","author":"Danese","year":"2018","journal-title":"J. Crohns. Colitis."},{"key":"10.1016\/j.imlet.2024.106935_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.02.009","article-title":"Targeting the S1P receptor signaling pathways as a promising approach for treatment of autoimmune and inflammatory diseases","volume":"154","author":"Stepanovska","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.imlet.2024.106935_bib0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbi.2018.03.009","article-title":"FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus","volume":"70","author":"Shi","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.imlet.2024.106935_bib0026","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12974-019-1441-4","article-title":"FTY720 controls disease severity and attenuates sciatic nerve damage in chronic experimental autoimmune neuritis","volume":"16","author":"Kremer","year":"2019","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.imlet.2024.106935_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110731","article-title":"FTY720 attenuates acute colitis via colonic T cells reduction and inhibition of M1 macrophages polarization independent of CCR2-mediated monocytes input","volume":"123","author":"Yang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.imlet.2024.106935_bib0028","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.imlet.2024.106935_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The role of JAK\/STAT signaling pathway and its inhibitors in diseases","volume":"80","author":"Xin","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.imlet.2024.106935_bib0030","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41388-020-01566-8","article-title":"STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis","volume":"40","author":"Lin","year":"2021","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.imlet.2024.106935_bib0031","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1073\/pnas.1913997117","article-title":"STAT3 signaling in myeloid cells promotes pathogenic myelin-specific T cell differentiation and autoimmune demyelination","volume":"117","author":"Lu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2024.106935_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.572858","article-title":"Th17\/Treg-related transcriptional factor expression and cytokine profile in patients with rheumatoid arthritis","volume":"11","author":"Paradowska-Gorycka","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2024.106935_bib0033","doi-asserted-by":"crossref","first-page":"C699","DOI":"10.1152\/ajpcell.00376.2021","article-title":"Nephronectin influences EAE development by regulating the Th17\/Treg balance via reactive oxygen species","volume":"322","author":"Honda","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.imlet.2024.106935_bib0034","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8813558","article-title":"The Function and role of the Th17\/Treg cell balance in inflammatory bowel disease","volume":"2020","author":"Yan","year":"2020","journal-title":"J. Immunol. Res."},{"issue":"3","key":"10.1016\/j.imlet.2024.106935_bib0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","article-title":"B cell depletion therapies in autoimmune disease: advances and mechanistic insights","volume":"20","author":"Lee","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.imlet.2024.106935_bib0036","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202149675","article-title":"Targeting B cells and plasma cells in autoimmune diseases: from established treatments to novel therapeutic approaches","volume":"53","author":"Merino-Vico","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2024.106935_bib0037","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.imlet.2023.06.005","article-title":"Targeting plasma cells in systemic autoimmune rheumatic diseases - promises and pitfalls","volume":"260","author":"Steinmetz","year":"2023","journal-title":"Immunol. Lett."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247824001093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247824001093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T05:47:21Z","timestamp":1733464041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247824001093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":37,"alternative-id":["S0165247824001093"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2024.106935","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fingolimod, an antagonist of sphingosine 1-phosphate, ameliorates Sj\u00f6gren's syndrome by reducing the number of STAT3\u2013induced germinal center B cells and increasing the number of Breg cells","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2024.106935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}],"article-number":"106935"}}